Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

In today's Asking Eric column, R. Eric Thomas responds to someone who is disappointed their friends didn't notice their ...

Dear Eric: Regarding your response to “What to Say”, who didn’t know how to address a friend’s Ozempic weight loss: ...

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

Experts said that the novel combination of a GLP-1 and amylin analogue will help obese patients with and without diabetes ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...